PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Sep-2025 PulpFixin Names Chad Jenkins Chief Executive Officer ACCESS Newswire
08-Sep-2025 NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND NRG Therapeutics
08-Sep-2025 SOLSTICE HEALTH Ranks No. 1520 on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies ACCESS Newswire
08-Sep-2025 Medical Care Technologies Inc. (OTC PINK:MDCE) Slashes Outstanding Share Count by 680,000,000 Shares ACCESS Newswire
08-Sep-2025 Locate Bio Expands RESTORE Clinical Study to the United States Following FDA IDE Approval Businesswire
08-Sep-2025 CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study ACCESS Newswire
08-Sep-2025 ProductLife Group Expands to Deliver Localized Expertise & Enhanced Client Support in Japan ProductLife Group
08-Sep-2025 Lunai Bioworks Strengthens European Strategy Through Restructuring ACCESS Newswire
08-Sep-2025 Tiziana Life Sciences Announces Purchase of Shares by Chairman Tiziana Life Sciences
08-Sep-2025 ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe ONWARD Medical
08-Sep-2025 From Telehealth to Trust: Flash Survey of WHX Attendees on the Next Wave of Middle East Digital Health Startups ACCESS Newswire
08-Sep-2025 CS Diagnostics Corp. Submits Patent Application For CS-Protect Hydrogel in the US Market ACCESS Newswire
08-Sep-2025 Remedium Bio Announces Strategic Collaboration With Lilly to Develop Gene Therapies for Obesity and Type 2 Diabetes ACCESS Newswire
08-Sep-2025 Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025 Businesswire
08-Sep-2025 Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025 Businesswire
08-Sep-2025 Stanford University Secures NIH Grant to Advance tiakis Biotech´s Elafin (Tiprelestat) Through a U.S. Phase II Trial in Pulmonary Arterial Hypertension tiakis Biotech AG
08-Sep-2025 Senzime to Present at the European Growth Virtual Investor Conference on September 11 ACCESS Newswire
08-Sep-2025 Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) ACCESS Newswire
08-Sep-2025 Wearable Injectors Market Key Players Analysis, Opportunities and Growth Forecast to 2035 Market Business Insights
08-Sep-2025 Biodexa Moves Into Phase 3 With eRapa For FAP With First Patients Enrolled ACCESS Newswire